Both ATP sites of human P-glycoprotein are essential but not symmetric

被引:127
作者
Hrycyna, CA
Ramachandra, M
Germann, UA
Cheng, PW
Pastan, I
Gottesman, MM
机构
[1] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA
[2] NCI, Mol Biol Lab, Div Basic Sci, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1021/bi991115m
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human P-glycoprotein (P-gp) is a cell surface drug efflux pump that contains two nucleotide binding domains (NBDs), Mutations were made in each of the Walker B consensus motifs of the NBDs at positions D555N and D1200N, thought to be involved in Mg2+ binding. Although the mutant and wild-type P-gps were expressed equivalently at the cell surface and bound the drug analogue [I-125]iodoarylazidoprazosin ([I-125]IAAP) comparably, neither of the mutant proteins was able to transport fluorescent substrates nor had detectable basal nor drug-stimulated ATPase activities. The wild-type and D1200N P-gps were labeled comparably with [alpha-P-32]-8-azido-ATP at a subsaturating concentration of 2.5 mu M, whereas labeling of the D555N mutant was severely impaired. Mild trypsin digestion, to cleave the protein into two halves, demonstrated that the N-half of the wild-type and D1200N proteins was labeled preferentially with [alpha-P-32]-8-azido-ATP. [alpha-P-32]-8-Azido-ATP labeling at 4 degrees C was inhibited in a concentration-dependent manner by ATP with half-maximal inhibition at approximately 10-20 mu M for the P-gp-D1200N mutant and wild-type P-gp. A chimeric protein containing two N-half NBDs was found to be functional for transport and was also asymmetric with respect to [alpha-P-32]-8-azido-ATP labeling, suggesting that the context of the ATP site rather than its exact sequence is an important determinant for ATP binding. By use of [alpha-P-32]-8-azido-ATP and vanadate trapping, it was determined that the C-half of wild-type P-gp was labeled preferentially under hydrolysis conditions; however, the N-half was still capable of being labeled with [alpha-P-32]-8-azido-ATP. Neither mutant was labeled under vanadate trapping conditions, indicating loss of ATP hydrolysis activity in the mutants. In confirmation of the lack of ATP hydrolysis, no inhibition of [I-125]IAAP labeling was observed in the mutants in the presence of vanadate. Taken together, these data suggest that the two NBDs are asymmetric and intimately linked and that a conformational change in the protein may occur upon ATP hydrolysis. Furthermore, these data are consistent with a model in which binding of ATP to one site affects ATP hydrolysis at the second site.
引用
收藏
页码:13887 / 13899
页数:13
相关论文
共 55 条
[1]  
ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197
[2]  
ALSHAWI MK, 1994, J BIOL CHEM, V269, P8986
[3]   Relation between the turnover number for vinblastine transport and for vinblastine-stimulated ATP hydrolysis by human P-glycoprotein [J].
Ambudkar, SV ;
Cardarelli, CO ;
Pashinsky, I ;
Stein, WD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (34) :21160-21166
[4]   PARTIAL-PURIFICATION AND RECONSTITUTION OF THE HUMAN MULTIDRUG-RESISTANCE PUMP - CHARACTERIZATION OF THE DRUG-STIMULATABLE ATP HYDROLYSIS [J].
AMBUDKAR, SV ;
LELONG, IH ;
ZHANG, JP ;
CARDARELLI, CO ;
GOTTESMAN, MM ;
PASTAN, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (18) :8472-8476
[5]  
ARCECI RJ, 1992, BLOOD, V80, P1528
[6]  
ARNES GF, 1986, ANNU REV BIOCHEM, V55, P397
[7]   DISCRETE MUTATIONS INTRODUCED IN THE PREDICTED NUCLEOTIDE-BINDING SITES OF THE MDR1 GENE ABOLISH ITS ABILITY TO CONFER MULTIDRUG RESISTANCE [J].
AZZARIA, M ;
SCHURR, E ;
GROS, P .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (12) :5289-5297
[8]   Characterization of the human multidrug resistance protein containing mutations in the ATP-binding cassette signature region [J].
Bakos, E ;
Klein, I ;
Welker, E ;
Szabo, K ;
Muller, M ;
Sarkadi, B ;
Varadi, A .
BIOCHEMICAL JOURNAL, 1997, 323 :777-783
[9]  
BECK WT, 1979, CANCER RES, V39, P2070
[10]  
BRUGGEMANN EP, 1991, BIOTECHNIQUES, V10, P202